EC approves Bristol Myers Squibb’s follicular lymphoma CAR T therapy
The EC has granted expanded approval to BMS' Breyanzi, to treat adults with relapsed or refractory follicular lymphoma (FL).
The EC has granted expanded approval to BMS' Breyanzi, to treat adults with relapsed or refractory follicular lymphoma (FL).
What's Your Reaction?
